ストックスクリーナーアプリを入手
20.13
2.75%
0.52
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Enterprise value to EBIT forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Crude Oil Gains 2%; Comcast Shares Spike Higher - Benzinga
Amphastar Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $22, Implies 1% Upside - TradingView
AMPH Downgraded by B of A Securities -- Price Target Lowered to $20 - GuruFocus
BofA cuts Amphastar stock rating on limited growth visibility By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – LS:A11664 - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth-Defensive Index - marketscreener.com
Amphastar Pharmaceuticals, Inc.(NasdaqGS: AMPH) added to Russell 2000 Dynamic Index - marketscreener.com
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – GETTEX:29A - TradingView
Price to book forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Price to sales forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Price to earnings forward of Amphastar Pharmaceuticals, Inc. – LS:A11664 - TradingView
Amphastar Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:AMPH) - TradingView
AMPH Forecast — Price Target — Prediction for 2027 - TradingView
Amphastar Pharmaceuticals Inc (AMPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Over-the-Counter Rextovy Cleared for Opioid Overdose Treatment - Clinical Pain Advisor
Amphastar Pharmaceuticals Inc (AMPH) Institutional Confidence - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AMPH Technical Analysis & Stock Price Forecast - Intellectia AI
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Amphastar Pharmaceuticals Inc - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Naloxone Nasal Spray Gets Third OTC Brand as FDA Approves Rextovy by Amphastar - Tech Times
Amphastar Pharmaceuticals (AMPH) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Challenging QuarterFull Year Guidance - newsline.com
(AMPH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Healthcare Stock Picks: RadNet and Amphastar to Sell, One Stock to Watch | June 2026News and Statistics - IndexBox
Amphastar Pharmaceuticals pivots to proprietary drugs, biosimilars for growth - MSN
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth - MarketBeat
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts - Yahoo Finance
Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged - GlobeNewswire
Amphastar Pharmaceuticals sees generic Atrovent fueling 2026 growth despite BAQSIMI drag - MSN
Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 - Moomoo
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag - MarketBeat
Amphastar (AMPH) director awarded RSUs and options with tax withholding update - Stock Titan
Amphastar Pharmaceuticals (AMPH) director receives RSUs and options grant - Stock Titan
Deflin Gayle awarded RSUs and stock options at Amphastar (NASDAQ: AMPH) - Stock Titan
Amphastar (AMPH) director Diane Gerst receives RSUs and stock option grant - Stock Titan
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
Amphastar (AMPH) holders approve directors, EY auditor and annual say-on-pay - Stock Titan
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ZASLOFF MICHAEL Amoomoo - Moomoo
(AMPH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty - Yahoo Finance
Amphastar (AMPH) Q1 2026 Earnings Transcript - AOL.com
Amphastar Pharmaceuticals (AMPH) Gains 1.4% as Stock Tests Resistance Near $20.34Retail Sentiment - newsline.com
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference - ACCESS Newswire
(AMPH) Risk Channels and Responsive Allocation - Stock Traders Daily
Amphastar Pharmaceuticals (AMPH) Shows Modest Gains as Stock Hovers Near Key ResistanceQuality Factor - The Legal Advocate
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19 - Insider Monkey
Has Amphastar Pharmaceuticals Bottomed Out After Its Steep Decline - Kavout | AI
Amphastar Earnings Call Balances Growth and Margin Strain - TipRanks
0.67%
1.91%
大文字化:
|
ボリューム (24 時間):